Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation

References

• Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer D M. The preterm labor syndrome. Ann NY Acad Sci 1994; 734: 414–429
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Kusanovic J P, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2006; 113(Suppl 3)17–42
   PubMed Web of Science ®Google Scholar
• Naeye R L, Ross S M. Amniotic fluid infection syndrome. Clin Obstet Gynaecol 1982; 9: 593–607
   PubMed Web of Science ®Google Scholar
• Minkoff H. Prematurity: infection as an etiologic factor. Obstet Gynecol 1983; 62: 137–144
   PubMed Web of Science ®Google Scholar
• Romero R, Mazor M, Wu Y K, Sirtori M, Oyarzun E, Mitchell M D, Hobbins J C. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12: 262–279
   PubMed Web of Science ®Google Scholar
• Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis A P, Hobbins J C. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161: 817–824
   PubMed Web of Science ®Google Scholar
• Ledger W J. Infection and premature labor. Am J Perinatol 1989; 6: 234–236
   PubMed Web of Science ®Google Scholar
• Gibbs R S, Romero R, Hillier S L, Eschenbach D A, Sweet R L. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166: 1515–1528
   PubMed Web of Science ®Google Scholar
• Brocklehurst P. Infection and preterm delivery. BMJ 1999; 318: 548–549
   PubMed Web of Science ®Google Scholar
• Goldenberg R L, Hauth J C, Andrews W W. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500–1507
   PubMed Web of Science ®Google Scholar
• Goncalves L F, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002; 8: 3–13
   PubMedGoogle Scholar
• Hirsch E, Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J Soc Gynecol Investig 2005; 12: 145–155
   PubMedGoogle Scholar
• Soto E, Romero R, Richani K, Espinoza J, Nien J K, Chaiworapongsa T, Santolaya-Forgas J, Edwin S S, Mazor M. Anaphylatoxins in preterm and term labor. J Perinat Med 2005; 33: 306–313
   PubMed Web of Science ®Google Scholar
• Yoon B H, Romero R, Kim C J, Jun J K, Gomez R, Choi J H, Syn H C. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995; 172: 960–970
   PubMed Web of Science ®Google Scholar
• Wenstrom K D, Andrews W W, Hauth J C, Goldenberg R L, DuBard M B, Cliver S P. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998; 178: 546–550
   PubMed Web of Science ®Google Scholar
• Yoon B H, Romero R, Moon J B, Shim S S, Kim M, Kim G, Jun J K. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001; 185: 1130–1136
   PubMed Web of Science ®Google Scholar
• Yoon B H, Oh S Y, Romero R, Shim S S, Han S Y, Park J S, Jun J K. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001; 185: 1162–1167
   PubMed Web of Science ®Google Scholar
• Gomez R, Romero R, Ghezzi F, Yoon B H, Mazor M, Berry S M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194–202
   PubMed Web of Science ®Google Scholar
• Romero R, Gomez R, Ghezzi F, Yoon B H, Mazor M, Edwin S S, Berry S M. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179: 186–193
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Kusanovic J P, Mazaki-Tovi S, Pineles B L, Erez O, Espinoza J, Hassan S S. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007; 50: 652–683
   PubMed Web of Science ®Google Scholar
• Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42: 1–8
   PubMed Web of Science ®Google Scholar
• Yoon B H, Romero R, Jun J K, Park K H, Park J D, Ghezzi F, Kim B I. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825–830
   PubMed Web of Science ®Google Scholar
• Yoon B H, Jun J K, Romero R, Park K H, Gomez R, Choi J H, Kim I O. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177: 19–26
   PubMed Web of Science ®Google Scholar
• Yoon B H, Romero R, Park J S, Kim C J, Kim S H, Choi J H, Han T R. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675–681
   PubMed Web of Science ®Google Scholar
• Dammann O, Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 2000; 12: 99–104
   PubMed Web of Science ®Google Scholar
• Gibbs R S. The relationship between infections and adverse pregnancy outcomes: an overview. Ann Periodontol 2001; 6: 153–163
   PubMedGoogle Scholar
• Patrick L A, Smith G N. Proinflammatory cytokines: a link between chorioamnionitis and fetal brain injury. J Obstet Gynaecol Can 2002; 24: 705–709
   PubMedGoogle Scholar
• Hagberg H, Mallard C, Jacobsson B. Role of cytokines in preterm labour and brain injury. BJOG 2005; 112(Suppl 1)16–18
   PubMed Web of Science ®Google Scholar
• Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med 2006; 34: 5–12
   PubMed Web of Science ®Google Scholar
• Holers V M. The complement system as a therapeutic target in autoimmunity. Clin Immunol 2003; 107: 140–151
   PubMed Web of Science ®Google Scholar
• Thurman J M, Holers V M. The central role of the alternative complement pathway in human disease. J Immunol 2006; 176: 1305–1310
   PubMed Web of Science ®Google Scholar
• Murphy K, Travers P, Walport M. Innate immunity 2008; Seventh: 39–103
   Google Scholar
• Walport M J. Complement. First of two parts. N Engl J Med 2001; 344: 1058–1066
   PubMed Web of Science ®Google Scholar
• Muller-Eberhard H J. Molecular organization and function of the complement system. Annu Rev Biochem 1988; 57: 321–47
   PubMed Web of Science ®Google Scholar
• Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien J K, Edwin S, Kim Y M, Hong J S, Mazor M. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005; 17: 239–245
   PubMed Web of Science ®Google Scholar
• Tichenor J R, Bledsoe L B, Opsahl M S, Cunningham D S. Activation of complement in humans with a first-trimester pregnancy loss. Gynecol Obstet Invest 1995; 39: 79–82
   PubMed Web of Science ®Google Scholar
• Mellor A L, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn D H. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001; 2: 64–68
   PubMed Web of Science ®Google Scholar
• Holers V M, Girardi G, Mo L, Guthridge J M, Molina H, Pierangeli S S, Espinola R, Xiaowei L E, Mao D, Vialpando C G, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195: 211–220
   PubMed Web of Science ®Google Scholar
• Caucheteux S M, Kanellopoulos-Langevin C, Ojcius D M. At the innate frontiers between mother and fetus: linking abortion with complement activation. Immunity 2003; 18: 169–172
   PubMedGoogle Scholar
• Girardi G, Salmon J B. The role of complement in pregnancy and fetal loss. Autoimmunity 2003; 36: 19–26
   PubMed Web of Science ®Google Scholar
• Girardi G. Complement inhibition keeps mothers calm and avoids fetal rejection. Immunol Invest 2008; 37: 645–659
   PubMed Web of Science ®Google Scholar
• Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien J K, Edwin S, Kim Y M, Hong J S, Goncalves L, et al. Preeclampsia and SGA differ in the maternal plasma complememt split products profile. J Soc Gynecol Investig 2005; 12(Suppl 2)148A
   Google Scholar
• Lynch A M, Murphy J R, Byers T, Gibbs R S, Neville M C, Giclas P C, Salmon J E, Holers V M. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol 2008; 198: 385–389
   PubMedGoogle Scholar
• Soto E, Richani K, Romero R, Espinoza J, Chaiworapongsa T, Nien J K, Edwin S, Kim Y M, Hong J S, Goncalves L, et al. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med 2005; 17: 247–252
   PubMed Web of Science ®Google Scholar
• Richani K, Romero R, Soto E, Espinoza J, Nien J K, Chaiworapongsa T, Refuerzo J, Blackwell S, Edwin S S, Santolaya-Forgas J, et al. Unexplained intrauterine fetal death is accompanied by activation of complement. J Perinat Med 2005; 33: 296–305
   PubMed Web of Science ®Google Scholar
• Elimian A, Figueroa R, Canterino J, Verma U, guero-Rosenfeld M, Tejani N. Amniotic fluid complement C3 as a marker of intra-amniotic infection. Obstet Gynecol 1998; 92: 72–76
   PubMed Web of Science ®Google Scholar
• Lynch A M, Gibbs R S, Murphy J R, Byers T, Neville M C, Giclas P C, Salmon J E, Van Hecke T M, Holers V M. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol 2008; 199: 354–358
   PubMedGoogle Scholar
• Alexander G R, Kogan M, Martin J, Papiernik E. What are the fetal growth patterns of singletons, twins, and triplets in the United States?. Clin Obstet Gynecol 1998; 41: 114–125
   PubMed Web of Science ®Google Scholar
• Gonzalez R P, Gomez R M, Castro R S, Nien J K, Merino P O, Etchegaray A B, Carstens M R, Medina L H, Viviani P G, Rojas I T. [A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. Rev Med Chil 2004; 132: 1155–1165
   PubMed Web of Science ®Google Scholar
• Pacora P, Chaiworapongsa T, Maymon E, Kim Y M, Gomez R, Yoon B H, Ghezzi F, Berry S M, Qureshi F, Jacques S M, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002; 11: 18–25
   PubMedGoogle Scholar
• Lesavre P H, Hugli T E, Esser A F, Muller-Eberhard H J. The alternative pathway C3/C5 convertase: chemical basis of factor B activation. J Immunol 1979; 123: 529–534
   PubMed Web of Science ®Google Scholar
• Kerr M A. Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology. Biochem J 1979; 183: 615–622
   PubMed Web of Science ®Google Scholar
• Niemann M A, Volanakis J E, Mole J E. Amino-terminal sequence of human factor B of the alternative complement pathway and its cleavage fragments, Ba and Bb. Biochemistry 1980; 19: 1576–1583
   PubMed Web of Science ®Google Scholar
• Gotze O, Muller-Eberhard H J. The C3-activator system: an alternate pathway of complement activation. J Exp Med 1971; 134: 90s–108s
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Sakiyama H, Tsuchida T, Yamaguchi K, Toyoguchi T, Masuda R, Moriya H. Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody. Ann Rheum Dis 1999; 58: 175–181
   PubMedGoogle Scholar
• Neumann E, Barnum S R, Tarner I H, Echols J, Fleck M, Judex M, Kullmann F, Mountz J D, Scholmerich J, Gay S, et al. Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum 2002; 46: 934–945
   PubMed Web of Science ®Google Scholar
• Walport M J. Complement and systemic lupus erythematosus. Arthritis Res 2002; 4(Suppl 3)S279–S293
   PubMedGoogle Scholar
• del Zoppo G J. In stroke, complement will get you nowhere. Nat Med 1999; 5: 995–996
   PubMed Web of Science ®Google Scholar
• Huang J, Kim L J, Mealey R, Marsh H C, Jr, Zhang Y, Tenner A J, Connolly E S, Jr, Pinsky D J. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999; 285: 595–599
   PubMed Web of Science ®Google Scholar
• Endresen I M, Relling G B, Tonder O, Myking O, Walther B T, Ursin H. Brief uncontrollable stress and psychological parameters influence human plasma concentrations of IgM and complement component C3. Behav Med 1991; 17: 167–176
   PubMed Web of Science ®Google Scholar
• Maes M, Hendriks D, Van G A, Demedts P, Wauters A, Neels H, Janca A, Scharpe S. Effects of psychological stress on serum immunoglobulin, complement and acute phase protein concentrations in normal volunteers. Psychoneuroendocrinology 1997; 22: 397–409
   PubMed Web of Science ®Google Scholar
• Burns V E, Edwards K M, Ring C, Drayson M, Carroll D. Complement cascade activation after an acute psychological stress task. Psychosom Med 2008; 70: 387–396
   PubMedGoogle Scholar
• Haeger M, Bengtson A, Karlsson K, Heideman M. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid. Obstet Gynecol 1989; 73: 551–556
   PubMedGoogle Scholar
• Kohler P F. Maturation of the human complement system. I. Onset time and sites of fetal C1q, C4, C3, and C5 synthesis. J Clin Invest 1973; 52: 671–677
   PubMedGoogle Scholar
• Holmes C H, Simpson K L. Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship. Baillieres Clin Obstet Gynaecol 1992; 6: 439–460
   PubMedGoogle Scholar
• Goldberg M, Luknar-Gabor N, Keidar R, Katz Y. Synthesis of complement proteins in the human chorion is differentially regulated by cytokines. Mol Immunol 2007; 44: 1737–1742
   PubMed Web of Science ®Google Scholar
• Holmes C H, Simpson K L, Okada H, Okada N, Wainwright S D, Purcell D F, Houlihan J M. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 1992; 22: 1579–1585
   PubMed Web of Science ®Google Scholar
• Vanderpuye O A, Labarrere C A, McIntyre J A. Expression of CD59, a human complement system regulatory protein, in extraembryonic membranes. Int Arch Allergy Immunol 1993; 101: 376–384
   PubMedGoogle Scholar
• Richani K, Soto E, Romero R, Han Y, Pineles B, Kim Y M, C E, Yoon B H, Kusanovic J, Kim C J. Decreased mRNA expression of complement regulatory proteins in chorioamnionitis. Am J Obstet Gynecol 2006; 195(Suppl 1)S71
   Google Scholar
• Adinolfi M, Gardner B, Wood C B. Ontogenesis of two components of human complement: beta1E and beta1C-1A globulins. Nature 1968; 219: 189–191
   PubMedGoogle Scholar
• Colten H R, Gordon J M, Borsos T, Rapp H J. Synthesis of the first component of human complement in vitro. J Exp Med 1968; 128: 595–604
   PubMedGoogle Scholar
• Gitlin D, Biasucci A. Development of gamma G, gamma A, gamma M, beta IC-beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin in the human conceptus. J Clin Invest 1969; 48: 1433–1446
   PubMedGoogle Scholar
• Colten H R. Ontogeny of the human complement system: in vitro biosynthesis of individual complement components by fetal tissues. J Clin Invest 1972; 51: 725–730
   PubMed Web of Science ®Google Scholar
• Fireman P, Zuchowski D A, Taylor P M. Development of human complement system. J Immunol 1969; 103: 25–31
   PubMedGoogle Scholar
• Ballow M, Fang F, Good R A, Day N K. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum. Clin Exp Immunol 1974; 18: 257–266
   PubMedGoogle Scholar
• Miyano A, Nakayama M, Fujita T, Kitajima H, Imai S, Shimizu A. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood. Diagn Clin Immunol 1987; 5: 86–90
   PubMedGoogle Scholar
• Stabile I, Nicolaides K H, Bach A, Teisner B, Rodeck C, Westergaard J G, Grudzinskas J G. Complement factors in fetal and maternal blood and amniotic fluid during the second trimester of normal pregnancy. Br J Obstet Gynaecol 1988; 95: 281–285
   PubMedGoogle Scholar
• Zilow G, Zilow E P, Burger R, Linderkamp O. Complement activation in newborn infants with early onset infection. Pediatr Res 1993; 34: 199–203
   PubMed Web of Science ®Google Scholar
• Enskog A, Bengtsson A, Bengtson J P, Heideman M, Andreasson S, Larsson L. Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress. Eur J Pediatr 1996; 155: 41–45
   PubMedGoogle Scholar
• Sonntag J, Brandenburg U, Polzehl D, Strauss E, Vogel M, Dudenhausen J W, Obladen M. Complement system in healthy term newborns: reference values in umbilical cord blood. Pediatr Dev Pathol 1998; 1: 131–135
   PubMedGoogle Scholar
• Sharma A, Prabhakar P, Sharma D P, Jayasinghe R G. Immunoglobulin and C3 levels in normal human amniotic fluid. West Indian Med J 1983; 32: 140–146
   PubMedGoogle Scholar
• Huffaker J, Witkin S S, Cutler L, Druzin M L, Ledger W J. Total complement activity in maternal sera, amniotic fluids and cord sera in women with premature labor, premature rupture of membranes or chorioamnionitis. Surg Gynecol Obstet 1989; 168: 397–401
   PubMedGoogle Scholar
• Soto E, Romero R, Richani K, Chaiworapongsa T, Yoon B H, Nien J K, Edwin S, Kusanovic J P, Espinoza J. Evidence for complement activation in premature labor associated with intra-amniotic infection. Am J Obstet Gynecol 2006; 195(Suppl 1)S74
   Google Scholar
• Hogasen A K, Overlie I, Hansen T W, Abrahamsen T G, Finne P H, Hogasen K. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency. J Perinat Med 2000; 28: 39–48
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Goncalves L F, Kusanovic J P, Friel L A, Nien J K. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006; 11: 317–326
   PubMed Web of Science ®Google Scholar
• Junqueira L C, Zugaib M, Montes G S, Toledo O M, Krisztan R M, Shigihara K M. Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation. Am J Obstet Gynecol 1980; 138: 273–281
   PubMed Web of Science ®Google Scholar
• Liggins G C. Cervical ripening as an inflammatory reaction. The Cervix in pregnancy and labor, clinical and biochemical investigation, D A Ellwood, A MB Anderson. Churchill Livingstone, Edinburgh 1981; 1–9
   Google Scholar
• Osman I, Young A, Ledingham M A, Thomson A J, Jordan F, Greer I A, Norman J E. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003; 9: 41–45
   PubMed Web of Science ®Google Scholar
• Thomson A J, Telfer J F, Young A, Campbell S, Stewart C J, Cameron I T, Greer I A, Norman J E. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod 1999; 14: 229–236
   PubMed Web of Science ®Google Scholar
• Keski-Nisula L, Aalto M L, Katila M L, Kirkinen P. Intrauterine inflammation at term: a histopathologic study. Hum Pathol 2000; 31: 841–846
   PubMed Web of Science ®Google Scholar
• Keelan J A, Blumenstein M, Helliwell R J, Sato T A, Marvin K W, Mitchell M D. Cytokines, prostaglandins and parturition–a review. Placenta 2003; 24(Suppl A)S33–S46
   PubMed Web of Science ®Google Scholar
• Romero R, Brody D T, Oyarzun E, Mazor M, Wu Y K, Hobbins J C, Durum S K. Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989; 160: 1117–1123
   PubMed Web of Science ®Google Scholar
• Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992; 166: 1576–1587
   PubMed Web of Science ®Google Scholar
• Opsjln S L, Wathen N C, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169: 397–404
   PubMed Web of Science ®Google Scholar
• Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993; 5: 81–88
   PubMed Web of Science ®Google Scholar
• Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991; 165: 813–820
   PubMed Web of Science ®Google Scholar
• Osmers R G, Blaser J, Kuhn W, Tschesche H. Interleukin-8 synthesis and the onset of labor. Obstet Gynecol 1995; 86: 223–229
   PubMed Web of Science ®Google Scholar
• Cohen J, Ghezzi F, Romero R, Ghidini A, Mazor M, Tolosa J E, Goncalves L F, Gomez R. GRO alpha in the fetomaternal and amniotic fluid compartments during pregnancy and parturition. Am J Reprod Immunol 1996; 35: 23–29
   PubMed Web of Science ®Google Scholar
• Esplin M S, Romero R, Chaiworapongsa T, Kim Y M, Edwin S, Gomez R, Gonzalez R, Adashi E Y. Amniotic fluid levels of immunoreactive monocyte chemotactic protein-1 increase during term parturition. J Matern Fetal Neonatal Med 2003; 14: 51–56
   PubMedGoogle Scholar
• Esplin M S, Peltier M R, Hamblin S, Smith S, Fausett M B, Dildy G A, Branch D W, Silver R M, Adashi E Y. Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor. Placenta 2005; 26: 661–671
   PubMed Web of Science ®Google Scholar
• Shynlova O, Tsui P, Dorogin A, Lye S J. Monocyte chemoattractant protein-1 (CCL-2) integrates mechanical and endocrine signals that mediate term and preterm labor. J Immunol 2008; 181: 1470–1479
   PubMed Web of Science ®Google Scholar
• Gotze O, Bianco C, Cohn Z A. The induction of macrophage spreading by factor B of the properdin system. J Exp Med 1979; 149: 372–386
   PubMed Web of Science ®Google Scholar
• Bianco C, Gotze O, Cohn Z A. Regulation of macrophage migration by products of the complement system. Proc Natl Acad Sci USA 1979; 76: 888–891
   PubMed Web of Science ®Google Scholar